Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vantrela ER in chronic low back pain
NCT01789970Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in chronic low back pain (CLBP), sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2013; status: completed.
02
Drugs
bupropion
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01789970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789970.